Technology
Health
Medical
Neuronetics
$12.489876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$12.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.18 (-1.42%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Neuronetics and other stocks, options, ETFs, and crypto commission-free!
About STIM
Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. Read More The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.
Employees
140
Headquarters
Malvern, Pennsylvania
Founded
2003
Market Cap
227.47M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
61.95K
High Today
$12.71
Low Today
$12.41
Open Price
$12.66
Volume
56.95K
52 Week High
$39.39
52 Week Low
$8.90
Collections
Technology
Health
Medical
Therapy
Advertising and Marketing
Education
Business Services
2018 IPO
Price Paid on Robinhood
38% Lower
Right Now
52 Week Low
$13.26
Average Price Paid
$20.22
52 Week High
$39.39
STIM Earnings
-$30.60
-$20.50
-$10.39
-$0.29
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 13, Pre-Market